BMO Capital analyst Ketan Mamtora raised the firm’s price target on Azek to $33 from $27 and keeps an Outperform rating on the shares. The company’s Q1 results were "tough" but the tone of the earnings call was "constructive" and the recent trends suggest modest upside potential to Azek’s FY23 EBITDA guidance, the analyst tells investors in a research note.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AZEK: